cancer weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of cancer weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Reports describe recent advances in cancer vaccines research
October 25th, 2005
Data on cancer vaccines are outlined in reports from the United States and United Kingdom. Study 1: Tumor-associated carbohydrate antigens are a possible avenue for cancer prevention. According to a study from the United States, "Here we examine the use of glycopeptides containing tumor-associated carbohydrate antigens (TACA) as potential preventive vaccines for carcinomas. Our recent results suggest that CD8+ T cells (CTL) are capable of recognizing TACA in a conventional class I MHC-restricted fashion. The Thomsen-Friedenreich antigen (TF), a disaccharide, and Tn, its immediate precursor, are TACA largely expressed in carcinomas." ...
Source: cancer weekly (2005-10-25)
|
